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Abstract
Background: Bronchopulmonary manifestations of Crohn disease have been rarely described in
children, including both subclinical pulmonary involvement and severe lung disease.
Case presentation: A 6.5-year-old girl is described with early recurrent bronchopulmonary
symptoms both at presentation and in the quiescent phase of Crohn disease. Pulmonary function
tests (lung volumes and flows, bronchial reactivity and carbon monoxide diffusing capacity) were
normal. Bronchoalveolar cytology showed increased (30%) lymphocyte counts and bronchial
biopsy revealed thickening of basal membrane and active chronic inflammation.
Conclusions: Clinical and histological findings in our young patient suggest involvement of both
distal and central airways in an early phase of lung disease. The pathogenesis of Crohn disease-
associated lung disorders is discussed with reference to the available literature. A low threshold
for pulmonary evaluation seems to be advisable in all children with CD.
Background
Bronchopulmonary manifestations of Crohn disease
(CD) in children have been rarely described up to now.
As it was already observed in adults [1–3], latent pulmo-
nary involvement is likely to occur also in children with
CD [4,5] but few cases of severe lung disease have been
reported in the pediatric age [6–10]. We describe a girl
who presented early recurrent bronchopulmonary symp-
toms both at presentation and in the quiescent phase of
CD.
Case presentation
A 6.5-year-old Caucasian girl, was admitted reporting a
6-month history of recurrent, bilateral hip arthralgia and
recent appearance of abdominal pain and non-bloody di-
arrhoea, fever and weight loss. Lung examination sug-
gested left lower lobe bronchopneumonia that was
confirmed by chest x-ray. Weight and height were 24 kg
(+1 SD) and 123 cm (+1 SD) respectively. Erythrocyte
sedimentation rate (ESR) was 43 mm/h, C-reactive pro-
tein (CRP) 190 mg/L and haemoglobin concentration 83
g/L. Mantoux testing (1/1000) was negative and serum
immunoglobulins and angiotensin converting enzyme
activity were in the normal range. She was HLA-B27 pos-
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showed bilateral, clear joint effusion. Esophagogas-
troduodenoscopy was normal and duodenal mucosa bi-
opsies showed signs of active chronic inflammation. At
colonoscopy, descending and sigmoid colon and rectum
had inflamed and easily bleeding mucosa. lleum and as-
cending colon were normal. Mucosal biopsy specimens
showed extended chronic inflammation with non-case-
ating epithelioid granulomas in distal colon consistent
with the diagnosis of Crohn colitis. The initial treatment
consisted of semielemental diet, 1 mg/kg oral prednisone
daily, 1 g sulphasalazine daily, oral metronidazole and in-
travenous ampicillin. Clinical remission of both CD and
arthritis was rapidly obtained and pulmonary symptoms
and radiological abnormalities resolved. Prednisone was
discontinued after three months and sulphasalazine was
switched to 1.2 g mesalazine daily after two months. No
relapse of CD has been observed since then.
Five months after diagnosis of CD, she had cough and
low grade fever and a chest radiograph showed paren-
chymal density in the middle lobe. Chest auscultation
was negative, ESR and CRP were normal, leukocyte
count was 5600 cells/mm3. Three weeks later, at a con-
trol chest x-ray, middle lobe was normal while a paren-
chymal density in the upper right lobe appeared (Figure
1). Lung examination was normal and again serologic
markers of inflammation were negative. Serum antibod-
ies for Legionella pneumophila, Chlamidia pneumoni-
ae, Mycoplasma pneumoniae and respiratory viruses
were negative and allergic bronchopulmonary aspergil-
losis and hypersensitivity pneumonitis were ruled out.
Sweat test was normal. Routine pulmonary function
tests were within the normal range (FVC 109%, FEV1
102%, FEF 25–75 118% of predicted values). At bron-
choscopy no endoluminal alterations were observed, cy-
tology of bronchoalveolar aspirate had increased
lymphocyte counts with 70% macrophages and 30%
lymphocytes. Staphylococcus aureus was isolated from
the aspirate and stains and culture for mycobacteria and
moulds were negative. Lymphocyte typing in blood and
bronchoalveolar lavage (BAL) was unremarkable (Table
1). Multiple bronchial biopsies showed evident thicken-
ing of basal membrane, angiectasies and active chronic
inflammation of the tonaca propria (Figure 2). Antimi-
crobial therapy was discontinued after ten days and radi-
ological abnormalities completely resolved. Colonoscopy
with multiple biopsies confirmed the remission of Crohn
colitis (Pediatric Crohn Disease Activity Index = 5).
Figure 1
Chest radiograph. Parenchymal density in the right upper
lobe.
Figure 2
Bronchial biopsy. Photomicrograph (× 400) of bronchial
mucosa showing remarkable basement membrane thickening
(asterisks) and mild-moderate submucosal chronic inflamma-
tory infiltrate (i). The epithelium is normal.
Table 1: Lymphocyte typing in blood and in bronchoalveolar 
lavage.
Lymphocyte typing Blood Bronchoalveolar lavage
CD3+ (%) 72 94
CD4+ (%) 45 49
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was asymptomatic, was unremarkable. Lung volumes
were measured in a constant-volume whole-body
plethysmograph, showing normal total lung capacity
(98% of the predicted value), functional residual capacity
(101% predicted) and residual volume (76% predicted).
Spirometry was measured by means of a 12-L bell
spirometer (Collins) revealing a normal shaped flow-vol-
ume curve, as well as normal forced expiratory volume in
1 sec. (FEV1, 115% predicted), forced vital capacity (FVC,
112% predicted) and FEV1/FVC (89% predicted). No
change was observed after the inhalation of salbutamol
200 mcg. Bronchial hyperreactivity (BHR) was tested
and ruled out by a methacholine provocation test. The
diffusing capacity was also normal with a transfer factor
for carbon monoxide (TLCO) of 103% predicted.
A further episode of radiological lung density in the left
lower lobe occurred two months later (Figure 3). The pa-
tient was treated with oral amoxicillin and prednisone
for eight days with prompt clinical and radiological re-
sponse.
Discussion
CD should be regarded as a multisystem disorder that in-
volves mainly the gastrointestinal tract. Although the
overall prevalence of concomitant bronchopulmonary
manifestations has been evaluated as low as 0.4% [11],
subclinical involvement in at least half of adults with CD
has been demonstrated by some authors [1,3,12,13] sug-
gesting underlying bronchial inflammation. In children
with CD, pulmonary abnormalities have been anecdotal-
ly reported, including non-caseating epithelioid granulo-
mas [6,7,9,10], bronchiolitis obliterans [6],
desquamative interstitial pneumonitis [14] and bron-
chopulmonary suppuration [1], as well as respiratory
function abnormalities in asymptomatic children [4,5].
The clinical features of bronchopulmonary involvement
in our patient seem to be interesting for several reasons.
The first is that respiratory symptoms appeared in a
young girl concurrently with the early manifestations of
intestinal disease. Lung abnormalities were not directly
related to the degree of activity of intestinal disease, as
suggested by the second colonoscopy that confirmed his-
tological remission of CD. If we make the hypothesis that
in CD a common antigenic stimulus may activate the lo-
cal immune system both in the gut and the lung [7], we
might argue that the reactivity of each organ is likely to
develop in a partially independent way. Early involve-
ment of the lung in children with CD was also observed
by Munck et al. [5] who showed in patients at diagnosis
a significant impairment of TLCO suggesting an intersti-
tial pulmonary process.
The results of bronchoalveolar cytology and of bronchial
biopsy are consistent with involvement of both distal and
central airways. The increased percentage of lym-
phocytes observed in BAL indicates a lymphocyte alveo-
litis resembling that already observed in adults with CD
or other granulomatous diseases [1] and in the child de-
scribed by Minic et al. [9]. Thickening of bronchial basal
membrane in the absence of granulomatous lesions is an
unusual finding in children with CD-associated lung dis-
ease. Similar histopathological findings, due to increased
subepithelial collagen deposition beneath the basal
membrane, have been reported in other chronic respira-
tory disorders with a strong inflammatory component,
such as asthma, chronic bronchitis and tuberculosis [15].
Unfortunately, biopsy specimens were very scarce and
we cannot exclude that the evidence of granulomas may
have been missed.
Lung abnormalities observed in our patient were unre-
lated to pharmacological treatment. Respiratory involve-
ment was concurrent with the diagnosis of CD and
recurred after three months from sulphasalazine with-
drawal. Neither peripheral eosinophilia nor eosinophilia
in the BAL – typical signs of mesalamine-induced lung
disease [16] – were observed and mesalamine had not to
be withdrawn.
Respiratory function tests were normal. In particular,
there was no evidence of BHR or reduced carbon monox-
ide diffusing capacity. BHR was recently observed in 71%
Figure 3
Chest radiograph. Lung density in the left lower lobe.
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CD or ulcerative colitis [3] and did not seem to be influ-
enced neither by activity nor by treatment or duration of
CD. The pathogenesis of BHR in CD is still unknown but
it may be a consequence of subclinical bronchial inflam-
mation, induced by the bronchial homing of lymphocytes
activated in the intestinal mucosa. Impairment of TLCO,
suggesting an interstitial pulmonary process, has been
reported in 19/20 children during active CD and in 5/10
during remission [5]. The apparent discrepancy, be-
tween histological and cytological abnormalities and the
absence of functional anomalies in our patient, may be
due to the still unexplained variability of these phenom-
ena in CD, or to the early phase of lung disease in which
studies were performed.
There is increasing evidence that CD-associated respira-
tory disease represents a problem also in the pediatric
age. Although it is not yet clear if these patients represent
a subset of CD population and if they need a different
therapeutic approach, a low threshold for pulmonary
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